Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	91421
Country	China

Received	2023-12-28 08:35
Peer-Review Started	2023-12-28 08:35
To Make the First Decision
Return for Revision	2024-04-11 04:04
Revised	2024-04-24 12:02
Second Decision	2024-05-13 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-05-13 05:33
Articles in Press	2024-05-13 05:33
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-06-24 00:50
Publish the Manuscript Online	2024-07-12 15:55

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	Oncolytic virotherapy for hepatocellular carcinoma: A potent immunotherapeutic landscape
Manuscript Source	Invited Manuscript
All Author List	Rong Xiao, Hao Jin, Fang Huang, Biao Huang, Hui Wang and Yi-Gang Wang
Funding Agency and Grant Number	Funding Agency Grant Number Public Welfare Technology Project of Zhejiang Province No. LGF21H160033 Zhejiang Medical Technology Plan Project No. 2021KY047 Hangzhou Medical Health Science and Technology Project No. B20220173
Corresponding Author	Yi-Gang Wang, PhD, Associate Professor, Professor, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, No. 2 Street of Xiasha District, Hangzhou 310018, Zhejiang Province, China. wangyigang43@163.com
Key Words	Oncolytic virus; Immunotherapeutic; Hepatocellular carcinoma; Virotherapy; Editorial
Core Tip	Since the discovery of oncolytic virus, various preclinical studies and clinical trials have been carried out on the application of virus therapy in hepatocellular carcinoma (HCC), and people have constantly tried to optimize the efficacy of this new drug. Based on this background, this editorial introduces oncolytic viruses for the treatment of HCC, including immunotherapy strategies, and looks forward to more good clinical results.
Publish Date	2024-07-12 15:55
Citation	<p>Xiao R, Jin H, Huang F, Huang B, Wang H, Wang YG. Oncolytic virotherapy for hepatocellular carcinoma: A potent immunotherapeutic landscape. <i>World J Gastrointest Oncol</i> 2024; 16(7): 2867-2876</p>
URL	https://www.wjgnet.com/1948-5204/full/v16/i7/2867.htm
DOI	https://dx.doi.org/10.4251/wjgo.v16.i7.2867

Full Article (PDF)	WJGO-16-2867-with-cover.pdf
Manuscript File	91421_Auto_Edited-YJP.docx
Answering Reviewers	91421-answering-reviewers.pdf
Audio Core Tip	91421-audio.mp3
Conflict-of-Interest Disclosure Form	91421-conflict-of-interest-statement.pdf
Copyright License Agreement	91421-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	91421-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	91421-non-native-speakers.pdf
Peer-review Report	91421-peer-reviews.pdf
Scientific Misconduct Check	91421-scientific-misconduct-check.png
Scientific Editor Work List	91421-scientific-editor-work-list.pdf
CrossCheck Report	91421-crosscheck-report.pdf